ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Passage Bio Inc

Passage Bio Inc (PASG)

1.2699
0.0499
( 4.09% )
Updated: 09:36:53

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.2699
Bid
1.22
Ask
1.27
Volume
711
1.22 Day's Range 1.2699
0.5751 52 Week Range 1.79
Market Cap
Previous Close
1.22
Open
1.22
Last Trade
350
@
1.2699
Last Trade Time
09:36:53
Financial Volume
$ 878
VWAP
1.2342
Average Volume (3m)
364,492
Shares Outstanding
55,598,796
Dividend Yield
-
PE Ratio
-0.66
Earnings Per Share (EPS)
-1.84
Revenue
-
Net Profit
-102.06M

About Passage Bio Inc

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
Passage Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PASG. The last closing price for Passage Bio was $1.22. Over the last year, Passage Bio shares have traded in a share price range of $ 0.5751 to $ 1.79.

Passage Bio currently has 55,598,796 shares outstanding. The market capitalization of Passage Bio is $67.83 million. Passage Bio has a price to earnings ratio (PE ratio) of -0.66.

PASG Latest News

Passage Bio to Present at Chardanโ€™s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative...

Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program

$10,000 scholarship to be awarded to a rising junior with a life science major attending a Pennsylvania-based four-year college or university Scholarship application deadline is April 26 for the...

Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights

Continued momentum in upliFT-D trial of PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin mutations (GRN) with clinical trial site expansion into Europe and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.06995.8251.21.281.1006937111.16598339CS
4-0.0901-6.6251.361.451.10061321101.29667887CS
120.299930.91752577320.971.790.93813644921.39032421CS
260.599989.53731343280.671.790.57515008141.00836436CS
520.279928.27272727270.991.790.57513533870.96520529CS
156-15.6701-92.503541912616.9419.840.57513316254.0548068CS
260-21.0001-94.297709923722.2738.230.57513162088.09355597CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.48
(104.19%)
26.17M
PEGYPineapple Energy Inc
$ 0.08365
(61.18%)
135.07M
AILEiLearningEngines Inc
$ 9.14
(35.21%)
6.89k
ULHUniversal Logistics Holdings Inc
$ 44.38
(34.93%)
16.46k
FRGTFreight Technologies Inc
$ 1.2188
(33.39%)
12.59M
ISUNiSun Inc
$ 0.1723
(-95.00%)
3.33M
NUWENewellis Inc
$ 0.157
(-45.67%)
7.32M
ICLKiClick Interactive Asia Group Ltd
$ 1.4672
(-42.01%)
85.89k
NWGLNature Wood Group Ltd
$ 12.14
(-27.95%)
10.11k
BACKIMAC Holdings Inc
$ 3.71
(-27.25%)
108.53k
PEGYPineapple Energy Inc
$ 0.084
(61.85%)
135.15M
KTRAKintara Therapeutics Inc
$ 0.177
(12.03%)
28.39M
BDRXBiodexa Pharmaceuticals PLC
$ 1.48
(104.19%)
26.17M
IVPInspire Veterinary Partners Inc
$ 0.0428
(12.34%)
16.43M
SQQQProShares UltraPro Short QQQ
$ 11.665
(-2.79%)
16.3M

PASG Discussion

View Posts
Sirpeter Sirpeter 1 month ago
Running... boom!!!
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 month ago
PASG under $2
๐Ÿ‘๏ธ0
glenn1919 glenn1919 1 month ago
PASG..........................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
PASG new 52 week high
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 2 months ago
PASG setting up nicely. Another beautiful call by the only true chartist around
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 2 months ago
Yup yup yup...
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 2 months ago
PASG...NEXT CRDL
๐Ÿ‘๏ธ0
glenn1919 glenn1919 2 months ago
PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
glenn1919 glenn1919 2 months ago
PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
PASG under $2
๐Ÿ‘๏ธ0
turning stone turning stone 3 months ago
As a new investor in PASG, I am looking forward to another high roller in the next number of years. I bought ARNA years ago at 1.90 and rode it out to $99/share when they were bought out by Phizer Pharm. I would like to have my 5 grandkids share the spoils on this one. With a multi-pipe line, a couple should make it to the end of the line with FDA approval. At the number of shares I purchased multiple times I can afford to run for the hills if a sudden disaster should hit this one. This company is 21 miles from my home and I will stop by shortly and have a sit down with their home-based PR. person. Good luck to all. You may also want to look at BLRX {BIO-Line Inc }










๐Ÿ‘๏ธ0
Walter4 Walter4 4 months ago
Data readout should be incoming shortly
👍️ 1
Monksdream Monksdream 8 months ago
PASG new 52 week low
๐Ÿ‘๏ธ0
catinhat catinhat 2 years ago
So...anybody out there? Thoughts on upcoming abstract, etc?

Recent long.
๐Ÿ‘๏ธ0
dealerschool2006 dealerschool2006 3 years ago
PASG down from panic selling due to the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $22.00 per share.
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock